FDA authorizes, w/ special controls, direct-to-consumer test that reports three mutations in the BRCA breast cancer genes. Test only reports 3 out of more than 1,000 known BRCA mutations & negative result doesn ’ t rule out increased cancer risk https://go.usa.gov/xnuGN  

FDA authorizes, w/ special controls, direct-to-consumer test that reports three mutations in the BRCA breast cancer genes. Test only reports 3 out of more than 1,000 known BRCA mutations & negative result doesn’t rule out increased cancer risk https://go.usa.gov/xnuGN 

Source: Food and Drug Adminstration (FDA): CDRHNew - March 6, 2018 Category: Medical Devices Authors: ( at US_FDA) Source Type: news